Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Health and Healthcare

Amgen : AMGN

All Amgen Articles

708 Articles

Jon C. Ogg | Jun 11, 2014 at 6:50 AM EDT

Short Sellers Remain Vigilant Against Top Biotech Stocks

ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger…

Jon C. Ogg | Jun 2, 2014 at 8:55 AM EDT

Analyst Cancer and Biotech Stock Picks From ASCO

ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty…

Douglas A. McIntyre | May 26, 2014 at 6:53 AM EDT

Google Top Company for Pay and Benefits

Google topped all companies in terms of best pay and benefits in a new survey by online jobs site Glassdoor.…

Jon C. Ogg | May 16, 2014 at 8:30 AM EDT

Top Biotech Stocks for Cancer Cures From Cowen

ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance…

Jon C. Ogg | Apr 23, 2014 at 3:35 PM EDT

Why Investors Are Not Chasing Gilead Endlessly Higher

ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock…

Jon C. Ogg | Apr 22, 2014 at 4:48 PM EDT

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) and Amgen Inc. (NASDAQ: AMGN) have both reported earnings. This is a definite difference in…

Jon C. Ogg | Apr 22, 2014 at 12:00 PM EDT

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off…

Trey Thoelcke | Apr 10, 2014 at 8:00 AM EDT

Who Bucked the Short Interest Trend in Biotech Stocks?

Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back…

Jon C. Ogg | Apr 3, 2014 at 10:50 AM EDT

Amgen Faces Cool Reception Over GSK Pact Termination

Amgen submitted an SEC Filing showing that, as of April 1, one of its subsidiaries and a GlaxoSmithKline subsidiary have…

Jon C. Ogg | Apr 2, 2014 at 3:37 PM EDT

Biotech Giants Now Priced Like Old World Drug Stocks

Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against…

Jon C. Ogg | Apr 2, 2014 at 8:20 AM EDT

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples…

Jon C. Ogg | Mar 27, 2014 at 8:55 AM EDT

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley…

Jon C. Ogg | Mar 27, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014.…

Trey Thoelcke | Mar 26, 2014 at 7:25 AM EDT

Short Sellers Find Renewed Interest in Biotech Stocks

After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early…

Trey Thoelcke | Mar 24, 2014 at 9:55 AM EDT

Top Biotechnology Stocks On Sale Again

For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from…

1 … 29 30 31 32 33 … 48

Amgen : AMGN

All Amgen Articles

Short Sellers Remain Vigilant Against Top Biotech Stocks

Analyst Cancer and Biotech Stock Picks From ASCO

Google Top Company for Pay and Benefits

Top Biotech Stocks for Cancer Cures From Cowen

Why Investors Are Not Chasing Gilead Endlessly Higher

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

Who Bucked the Short Interest Trend in Biotech Stocks?

Amgen Faces Cool Reception Over GSK Pact Termination

Biotech Giants Now Priced Like Old World Drug Stocks

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

Short Sellers Find Renewed Interest in Biotech Stocks

Top Biotechnology Stocks On Sale Again

Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

Live: Will ServiceNow’s Q2 Earnings Tonight Drive a Rebound After 38% YTD Decline?

VPFF: Virtus’s Latest Income Play Charges 0.80% to Beat Preferred Stock Indexes

This $222 Billion Vanguard ETF Is Trailing the S&P 500. That Almost Never Happens.

DVY’s 3.3% Yield Looks Weak Against 4.55% Treasury Rates Right Now

She Divorced at 66 and Her Income Never Changed. Her Medicare Bracket Did.

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here's the Math Retirees Miss.

The Ultimate Bull Run for NVIDIA, Micron, and SanDisk May Be Closer Than Investors Think

VPFF: Virtus’s Latest Income Play Charges 0.80% to Beat Preferred Stock Indexes

Amgen : AMGN

All Amgen Articles

Short Sellers Remain Vigilant Against Top Biotech Stocks

Analyst Cancer and Biotech Stock Picks From ASCO

Google Top Company for Pay and Benefits

Top Biotech Stocks for Cancer Cures From Cowen

Why Investors Are Not Chasing Gilead Endlessly Higher

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

Who Bucked the Short Interest Trend in Biotech Stocks?

Amgen Faces Cool Reception Over GSK Pact Termination

Biotech Giants Now Priced Like Old World Drug Stocks

Large Cap Biotechs Trading With Only Big Pharma P/E Ratios

Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks

Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More

Short Sellers Find Renewed Interest in Biotech Stocks

Top Biotechnology Stocks On Sale Again

Live: Will Alphabet Smash Q2 Earnings Tonight After Berkshire Hathaway’s Big Bet?

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

Live: Will ServiceNow’s Q2 Earnings Tonight Drive a Rebound After 38% YTD Decline?

VPFF: Virtus’s Latest Income Play Charges 0.80% to Beat Preferred Stock Indexes

This $222 Billion Vanguard ETF Is Trailing the S&P 500. That Almost Never Happens.

DVY’s 3.3% Yield Looks Weak Against 4.55% Treasury Rates Right Now

Featured Reads

She Divorced at 66 and Her Income Never Changed. Her Medicare Bracket Did.

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here's the Math Retirees Miss.